within Pharmacolibrary.Drugs.ATC.A;

model A01AC01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00018666666666666666,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0975,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A01AC01</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Triamcinolone is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties, used to treat a range of conditions such as oral inflammatory diseases (as a dental paste), dermatological disorders, and allergic reactions. It is approved and currently used in various formulations including topical, oral, inhalational, and injectable forms.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adults for oral topical (dental paste/buccal) administration; literature reporting specific parameters for the dental paste or topical oral form is lacking. Estimates are extrapolated from systemic use and closely related topical or oral administration data.</p><h4>References</h4><ol><li><p>Altamirano-Vallejo, JC, et al., &amp; Santos, A (2018). Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 34(5) 416–425. DOI:<a href=&quot;https://doi.org/10.1089/jop.2017.0099&quot;>10.1089/jop.2017.0099</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29584529/&quot;>https://pubmed.ncbi.nlm.nih.gov/29584529</a></p></li><li><p>Callen, JP (1981). Intralesional corticosteroids. <i>Journal of the American Academy of Dermatology</i> 4(2) 149–151. DOI:<a href=&quot;https://doi.org/10.1016/s0190-9622(81)70017-3&quot;>10.1016/s0190-9622(81)70017-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7217384/&quot;>https://pubmed.ncbi.nlm.nih.gov/7217384</a></p></li><li><p>Szefler, SJ (2001). Pharmacokinetics of intranasal corticosteroids. <i>The Journal of allergy and clinical immunology</i> 108(1 Suppl) S26–S31. DOI:<a href=&quot;https://doi.org/10.1067/mai.2001.115563&quot;>10.1067/mai.2001.115563</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11449203/&quot;>https://pubmed.ncbi.nlm.nih.gov/11449203</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A01AC01;
